The most compelling evidence for the dualistic nature of REG3A comes from studies in gastric and colorectal cancers, where its role oscillates between tumor-suppressive and oncogenic depending on experimental conditions and disease characteristics. This evidence concerns the gene REG3A and colorectal cancer.